If you are surmising that material from the cGMP facility will be ready prior to tox starting, I don't believe that is the case. Unless something has changed tox will be done with materials produced in the existing lab. I suppose it is possible that at some point next year the current lab materials could be supplemented with material from the cGMP prior to conclusion of tox, but I don't think that is the most likely scenario. Did I understand your statement correctly?
Market Data 
Markets 
AI
